Evaxion Biotech A/S
(EVAX)
undefined
undefined%
At close: undefined
0.91
-1.09%
After-hours Jan 03, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 73.00K | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 112.00 | 571.32K | 343.45K | 105.72K | 80.98K | 73.93K |
| Gross Profit | 72.89K | -571.32K | -343.45K | -105.72K | -80.98K | -73.93K |
| Operating Income | -22.20M | -25.26M | -25.83M | -16.57M | -10.86M | -5.63M |
| Interest Income | 154.00K | 2.83M | 2.04M | 216.00K | 9.00K | 2.00K |
| Pretax Income | -22.91M | -23.94M | -24.71M | -16.57M | -12.02M | -6.27M |
| Net Income | -22.13M | -23.17M | -24.53M | -15.02M | -11.20M | -5.54M |
| Selling & General & Admin | 10.35M | 8.21M | 6.25M | 5.67M | 2.63M | 1.88M |
| Research & Development | 11.92M | 17.06M | 19.58M | 10.90M | 8.22M | 3.73M |
| Other Expenses | n/a | n/a | n/a | n/a | 16.00K | 15.00K |
| Operating Expenses | 22.25M | 25.26M | 25.83M | 16.57M | 10.86M | 5.63M |
| Interest Expense | 897.00K | 1.51M | 915.00K | 223.00K | 1.22M | 698.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 22.27M | 25.26M | 25.83M | 16.57M | 10.86M | 5.63M |
| Income Tax | -791.22K | -772.00K | -178.00K | -1.56M | -825.00K | -735.00K |
| Shares Outstanding (Basic) | 2.73M | 2.36M | 1.95M | 1.62M | 1.62M | 1.92M |
| Shares Outstanding (Diluted) | 2.73M | 2.36M | 1.95M | 1.62M | 1.62M | 1.92M |
| EPS (Basic) | -8.11 | -9.8 | -12.58 | -9.27 | -6.91 | -2.88 |
| EPS (Diluted) | -8.11 | -9.8 | -12.58 | -9.27 | -6.91 | -2.88 |
| EBITDA | -21.40M | -22.58M | -24.17M | -16.46M | -11.90M | -6.18M |
| Depreciation & Amortization | 615.95K | 571.32K | 343.45K | 105.72K | 80.98K | 73.93K |